首页> 外文期刊>La Presse medicale >Merkel cell carcinoma: The first human cancer shown to be associated with a polyomavirus
【24h】

Merkel cell carcinoma: The first human cancer shown to be associated with a polyomavirus

机译:默克尔细胞癌:人类最早发现与多瘤病毒有关的癌症

获取原文
获取原文并翻译 | 示例
       

摘要

Merkel cell carcinoma (MCC) is a rare, malignant primary neuroendocrine cancer of the skin, usually affecting elderly, white people in sun-exposed areas. This is a highly aggressive tumor with strong propensity to metastasize. Surgery and radiation therapy remain the mainstay of treatment, with no curative treatment in case of disseminated metastases. Until 2008, MCC was thought to be caused by the malignant transformation of resident Merkel cells, but no investigation of a predominant molecular pathway that could be involved in MCC pathogenesis was successful. A real revolution in MCC understanding and management occurred in 2008, when a new human polyomavirus (MCPyV) was found to be the main etiological agent of this skin cancer. Following the discovery of MCPyV, the association of MCPyV with MCC has been confirmed worldwide, with detection of MCPyV in about 80% of MCCs. At the same time it had been shown that MCPyV infection is almost ubiquitous in healthy subjects, and MCPyV is thought to be persistent resident of the skin microbiome although the route of transmission, the host cell, the viral cycle and/or latency remain unknown. Most studies suggest that there may be two subtypes of MCC: MCPyV-positive (80%) and MCPyV-negative (20%) MCCs, and various studies have reported a better prognosis associated with MCPyV infection.
机译:默克尔细胞癌(MCC)是一种罕见的恶性皮肤原发性神经内分泌癌,通常会影响阳光照射区域的老年人,白人。这是一种高度侵袭性的肿瘤,具有很强的转移倾向。外科手术和放射疗法仍然是治疗的主要手段,如果发生转移,则无需治疗。直到2008年,MCC一直被认为是由驻留的默克尔细胞的恶性转化引起的,但是尚未成功研究可能参与MCC发病机理的主要分子途径。 MCC的认识和管理发生了一场真正的革命,2008年,一种新的人类多瘤病毒(MCPyV)被发现是该皮肤癌的主要病因。在发现MCPyV之后,全世界已确认MCPyV与MCC的关联,在大约80%的MCC中检测到MCPyV。同时,已经表明,MCPyV感染在健康受试者中几乎无处不在,尽管传播途径,宿主细胞,病毒周期和/或潜伏期仍然未知,但MCPyV被认为是皮肤微生物组的永久性居民。大多数研究表明,MCC可能有两种亚型:MCPyV阳性(80%)和MCPyV阴性(20%)MCC,并且各种研究都报告了与MCPyV感染相关的更好的预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号